Lithuania
Tuberculosis profile
| High MDR-TB burden |
Population  2012 3 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.09 (0.088–0.091) 3 (2.9–3)
Mortality (HIV+TB only) 0.014 (0.012–0.017) 0.47 (0.39–0.55)
Prevalence  (includes HIV+TB) 2.8 (1.3–5) 93 (42–164)
Incidence  (includes HIV+TB) 2 (1.8–2.3) 66 (58–75)
Incidence (HIV+TB only) 0.071 (0.062–0.08) 2.3 (2–2.6)
Case detection, all forms (%) 82 (72–93)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 726 (51) Relapse 204 (58)
Smear-negative 548 (38) Treatment after failure 35 (10)
Smear-unknown / not done 0 (0) Treatment after default 106 (30)
Extrapulmonary 156 (11) Other 5 (1)
Other 0 (0)      
Total new 1 430   Total retreatment 350  
           
Other (history unknown) 1        
Total new and relapse 1 634   Total cases notified 1 781  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 3.1 1.8 0.9
Age < 15 1 7 48
Laboratories 2012
Smear (per 100 000 population) 0.4
Culture (per 5 million population) 9.9
Drug susceptibility testing (per 5 million population) 9.9
Is second-line drug susceptibility testing available? Yes, in and outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 73   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 87  
Retreatment 33  
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 11 (9.5–14) 44 (39–49)
MDR-TB cases among notified pulmonary
TB cases
150 (120–170) 150 (140–170)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 1 017 (100%) 350 (100%) 1 368
Laboratory-confirmed MDR-TB cases 116 154 271
Patients started on MDR-TB treatment     271
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-16 Data: www.who.int/tb/data